Back to Resource Center

Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection

February 2014

Click to view Journal Article

Click for full info +

Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection

13 February 2014
In this Journal Article:
Health Risk(s):

  • HIV
  • HSV
  • STI / STD
  • Product Type(s):

  • Microbicides
  • Vaginal Cream/Gel
  • Topic(s):

  • Product Trials

  • Full Info:


    Resource Type:

    Journal Article

    Citation:

    McConville, C., Boyd, P., & Major, I. (2014). Clinical medicine insights. Women’s health, 7, 1.

    Authors:

    McConville, C., Boyd, P., & Major, I.

    Health Risks(s):

    • HIV
    • HSV
    • STI / STD

    Product type(s):

    • Microbicide
    • VaginalCream

    Topic(s):

    • Trials

        URL of resource:

        www.ncbi.nlm.nih.gov/pmc/articles/PMC3988671/

        Back to Resource Center